Some good news...biggest ETF from Sudan wants to invest 10000$ in TCDA stock when this one will be available on OTC market!!!!They were advised by Orbimed and others.Lets hope this business goes through.
r
Call prices are super high - over $1 for March $7.5 Market obviously expecting announcement of good news, or at least a high chance of good news at earnings this week (the sudden announcement of earnings was also rather puzzling).
J
Orbimed and Bakers Bros Are still holders ... Dan seems like he thinks he is smarter than the 2 top biotech hedge fund guys out there ...Hmm..
S
short term is not look good, may go in 3 or 4 range in next few weeks. Cash in hand will help to move in the long term. Going to accumulate little by little when it falls.
s
Long wait for results....
Need to wait till mod 2022 for clinical results so they could resubmit NDA. In the mean time company burns cash. AT the current rate 2/3 of cash will be gone and only 100M next year to be used for manufacturing setup. Net cash will be zero due to debt, so company will need to raise capital...
Good Luck to all and do your due diligence always...
M
This stock will get de-listed. I purchased it when it dropped from 30 to 15. Then it plummeted to 6. And now again to under 5. This is terrible. If you are risk taker, go ahead and buy. But I recommend avoiding!
Neutral
D
TCDA CEO just made the announcement:when the share price will reach 4,99$ the will have a very delightful promotion: buy one for 4,99 and get 1 free!!!!!This is great news.Definetely Orbimed and Bakers Bros will jump into this!!!!!!Great Co.Greatest Veverimer.Veverimer for ever.
D
My guess is great news for tomorrow....stock will move up from 4,82 to 4,83!!!!!
C
CEO has a 0/3 track record for bringing a product to market with FDA approval. I feel so bad for the underpaid scientists who signed onto this company with the hopes of making a difference. They did their part and made a drug that works just to have the marketing and clinical trial team throw their hard work straight into the trash can. How do you botch your clinical trials so badly? Did no one in any of these meetings mention that it might be bad if all of the clinical test subjects were Caucasians from Europe when your main target audience are minorities in the U.S.? Company is looking for a buyout but with the product in its current state the big drug companies smell blood in the water. Will be lucky to get pennies on the dollar right before they declare bankruptcy.
D
Such a great company to invest in....Orbimed,Berkshire,many others are buying all they can....Long life Veverimer....see U in 2099
D
TCDA will be a strong company,maybe better and bigger than Moderna.....just watch the news in 2071
D
Orbimed and Bakers Bros are buying more stock today
S
Cash on hand will slowly dilute throughout 2021 and 2022. At the end of 2022, company either dilute the stock or disappear completely.
D
I hope they will have Veverimer/Sudan style approved in the 4th quarter 2041
D
Orbimed and Bakers Bros Are still holders......this is very good news!!!!!!!!!!!!!!!!!!!!
D
The big question still remains: how long it take stock to go under 1$????
Y
Tricida is up 14.61% to 8.00
C
Holding strong.. any news now and it will pop back up
D
the bad thing is Sudan government will buy TCDA when stock will be listed at OTC MARKET
X
TCDA recovery will take years...
I managed to escape last Oct/Nov before it's first plummet from $14+ to $8+...now I am looking back...it's so scary...
Need to wait till mod 2022 for clinical results so they could resubmit NDA. In the mean time company burns cash. AT the current rate 2/3 of cash will be gone and only 100M next year to be used for manufacturing setup. Net cash will be zero due to debt, so company will need to raise capital...
Good Luck to all and do your due diligence always...
I purchased it when it dropped from 30 to 15. Then it plummeted to 6. And now again to under 5. This is terrible. If you are risk taker, go ahead and buy. But I recommend avoiding!
I managed to escape last Oct/Nov before it's first plummet from $14+ to $8+...now I am looking back...it's so scary...